Dataset Information

Cerebrospinal Fluid Proteomics of Frailty

ABSTRACT: Frailty is defined as a clinical syndrome. It reflects a decrease in physiological reserve capacities that alters the mechanisms of adaptation to stress. Its clinical expression is modulated by biological, physiological, social and environmental changes. Thus, the accumulation of declines in these multiple systems leads to vulnerability to adverse outcomes (Fried et al., 2001; Nourhashémi et al., 2001). Indeed, frailty increases the risk of disability, falls, hospitalization and death. Age is currently a major determinant of frailty but does not explain this syndrome alone. It has been estimated that the prevalence of frailty is 4% in people aged 65-69 years and increases to 26% in people aged over 85 years (Clegg et al., 2013). However, this parameter is not sufficient to understand why long-lived people can preserve their physical function even at extreme ages (Ayers et al., 2017). The characterization of frailty has therefore become a priority in order to put in place actions to reduce or delay its harmful consequences. Early diagnostic methods are needed to identify those at risk. The search for biomarkers is part of this approach. As a result, the search for biomarkers of frailty has led to the identification of several types of molecules linked to the inflammatory response (e.g. IL-6, CRP, TNF-α and homocysteine), to nutritional status (e.g. vitamin D, albumin) or even endocrine. metabolism (e.g. IGF-1 and testosterone) (Picca et al., 2022; Mailliez et al., 2020; Alvarez-Sanchez et al, 2020). The development of new analytical techniques now allows multiplexed analysis rather than an individual biomarker to characterize a biological profile of this complex and dynamic frailty syndrome (Picca et al., 2022). Proteomic analysis is the technique of choice for studying the complete protein content of a biological sample. This technique has already proven itself in the discovery of new biomarkers in age-related diseases such as Parkinson's disease (Raghunathan et al., 2022) and Alzheimer's disease (Bai et al., 2021). Several studies have already described the plasma proteomic profile of frailty (Shamsi et al., 2012; Lin et al., 2017; Landino et al., 2021; Sathyan et al., 2020; Verghese et al., 2021), highlighting the importance of biological pathways associated with frailty: immune response, coagulation pathway or lipid metabolism. On the other hand, the determination of the level of frailty of the patients thanks to a proteomic analysis could also make it possible to improve the prediction of this syndrome as well as its phenotyping. In a first work on plasma samples, Sathyan et al. constructed a frailty prediction model that was more strongly correlated with chronological age than observed clinical frailty (Sathyan et al., 2020). Cognitive impairment plays a key role in determining vulnerability to adverse outcomes (Cesari et al., 2013), leading to the proposal in 2013 of a concept and operational definition of “cognitive frailty”. (Sugimoto et al., 2022). Proteomic analysis of cerebrospinal fluid (CSF) is therefore an approach of choice for understanding brain responses to aging and frailty syndrome. Its analysis could allow the identification of new biomarkers linked to the frailty syndrome. Indeed, many of the CSF proteins are released by the various cells of the central nervous system (CNS). This biofluid thus reflects the molecular content of neuronal and glial cells. For this reason, any change in the composition of the CSF reflects the pathophysiological state of the brain (inflammation, infection, neurodegeneration...). CSF proteomics is therefore a technique of choice to comprehensively understand the cerebral pathogenic pathways linked to frailty. The PROLIPHYC cohort is composed of patients suspected of normal pressure hydrocephalus (NPH). We have previously shown that there is an association in these patients between an alteration of the biomechanical properties of the CNS and the frailty index, and that homocysteine is the only plasma macromolecule associated with these two clinical and biomechanical parameters (Vallet et al., 2020; Guillotin et al., 2022). In this new study, we sought to characterize the protein composition of CSF related to frailty by quantitative proteomic analysis. The second objective was to develop a model for predicting frailty from the abundance of CSF proteins. This model was then compared to the frailty estimated by the frailty index. Together, our results enabled us to highlight a possible link between inhibition of the expression of proteins involved in neurogenesis and the frailty index, then to propose a first proteomic profile of frailty in the CSF and a model for predicting frailty based on the biological signature of the CNS.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cerebrospinal Fluid Secreting Cell

DISEASE(S): Hydrocephalus

SUBMITTER: Emmanuelle Mouton Barbosa

LAB HEAD: Eric SCHMIDT

PROVIDER: PXD043497 | Pride | 2024-08-10

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 260

Publications

Cerebrospinal fluid proteomic profile of frailty: Results from the PROLIPHYC cohort.

Guillotin Sophie S Fulzele Amit A Vallet Alexandra A de Peredo Anne Gonzalez AG Mouton-Barbosa Emmanuelle E Cestac Philippe P Andrieu Sandrine S Burlet-Schiltz Odile O Delcourt Nicolas N Schmidt Eric E

Aging cell 20240502 7

Frailty is a clinical state reflecting a decrease in physiological reserve capacities, known to affect numerous biological pathways and is associated with health issues, including neurodegenerative diseases. However, how global protein expression is affected in the central nervous system in frail subject remains underexplored. In this post hoc cross-sectional biomarker analysis, we included 90 adults (52-85 years) suspected of normal pressure hydrocephalus (NPH) and presenting with markers of ne ...[more]

PMID: 38698559

Similar Datasets

Project description:Antimicrobial peptides (AMPs) are a group of molecules that occur naturally in all living organisms and help them to defend against various pathogens, including fungi, bacteria and viruses (Gan et al., 2021). AMPs have a low molecular mass (~2-50 amino acids), are rich in hydrophobic amino acids and have a net positive charge (Huan et al., 2020). Some stable antimicrobial peptides can bind to chitin, an insoluble homopolymer present in several types of biological materials, such as the cell wall of fungi, insects and crustacean shells; however, chitin is not present in plants. Some peptides, including chitinases, vicilins, lectins, 2S albumins and hevein-like peptides, can bind to a matrix composed of chitin. These peptides exhibit antimicrobial activity against bacteria and fungal pathogens, and they interact with fungal chitin through the chitin binding site, which plays a significant role in inhibiting fungal growth (Slezina and Odintsova, 2023). The binding site shares structural similarity with hevein, an antimicrobial peptide from the latex of Hevea brasiliensis (Willd. exA. Juss.) Müll. Arg. The main element of all hevein-like peptides is that a conservative chitin-binding site is one of their essential structural modules (Slavokhotova et al., 2017; Azmil et al., 2021). Hevein-like peptides are AMPs that are rich in cysteine, contain 29-45 amino acids and 5-7 residues contain glycine. A main feature of hevein-like peptides is a conservative chitin binding site with the amino acid sequence SXFGY/SXYGY, in which X is any amino acid residue (Beintema, 1994). In addition, these peptides are present in the plant cysteine-rich antimicrobial peptide superfamily, are 2-6 kDa in weight, contain 6-10 Cys residues and contain three to five disulfide bridges (Tam et al., 2015). They also possess structural motifs composed of three antiparallel beta sheets and a short α-helix, which are stabilized by 3-5 disulfide bonds (Odintsova et al., 2020). Previously, hevein-like peptides have been reported to exhibit activity against several fungal microorganisms with or without chitin in their cell wall (Slezina and Odintsova, 2023). The mechanism underlying the activity of hevein-like peptides is mainly through depolarization of hyphae membrane (Azmil et al., 2021). Recently, several hevein-like peptides have been isolated from several plant species, such as wheat (Odintsova et al., 2020), quinoa (Loo et al., 2021) and moringa (Sousa et al., 2020). These peptides exhibited activity against a range of microorganisms, such as F. oxysporum, F. culmorum, Bipolaris sorokininana, Alternaria alternata and Cladosporium cucumerinum (Odintsova et al., 2020). These findings have encouraged further studies on the application of these molecules against pathogenic fungi, as the molecules exhibit great activity and could be used to create new antifungal medications. Peppers and chilies originate from the tropical Americas and belong to 22 families of Solanaceae and the genus Capsicum; 35 of these species have been domesticated, while the others remain semidomesticated and wild. The plants are dispersed worldwide, and in Brazil, they are cultivated mainly in the states of Rio de Janeiro, Minas Gerais, Bahia and Goiás; among the various locations, Rio de Janeiro is a special center of diversity (Moscone et al., 2006). These plants are essential solanaceous vegetables with high world economic value. However, the growth, quality and yield of these plants are reduced by biotic (fungal, bactéria and virus infections and pests) and abiotic (drought, salinity and extreme temperatures) factors (Mittler, 2006; Wang et al., 2003). Several AMPs have been isolated from different organs of plants within the Capsicum genus (Oliveira et al., 2022). For example, a hevein-like peptide was identified from C. annuum leaves; this peptide is approximately 4.2 kDa and was named HEVCAN. In addition, the peptide belongs to the chitin-binding domain family and exhibits antimicrobial activity (Oliveira et al., 2022). Our research group has previously isolated and identified several other antimicrobial peptides, such as defensin (Gebara et al., 2020), LTP (Diz et al., 2011), protease inhibitors (Ribeiro et al., 2013) and chitin-binding peptides (Gonçalves et al., 2024), from Capsicum seeds. In this study, we used a chitin affinity column to purify peptide fractions from C. chinense seeds, and these fractions exhibited chitin-binding capacity and activity against yeasts.

Project description:Lysine malonylation is an evolutionarily conserved PTM from bacteria to mammals and involves malonyl-coenzyme (CoA) as a cofactor. Since the malonyl group has an acidic carboxylic group under physiological pH, malonylated lysine is negatively charged, which might impact on protein function and enzymatic activities. Like other short-chain acyl-CoAs, malonyl-CoA can be synthesized from its corresponding short-chain acyl salt, malonate, catalyzed by malonyl-CoA synthetase (Witkowski et al., 2011). In addition, malonyl-CoA can be produced during the carboxylation of acetyl-CoA by acetyl-CoA carboxylase (ACC), the carboxylation of acetyl-CoA by propionyl-CoA carboxylase, and the β-oxidation of old-chain-length dicarboxylic acids (Peng et al., 2011). Most studies on Kmal have been performed in mammalian systems and identified thousands of malonylated sites, revealing its role in the progress of diseases like type 2 diabetes, schizophrenia, and cardiac hypertrophy (Du et al., 2015; Smith et al., 2022; Wu et al., 2022). There has been increasing interest in dissecting the regulatory roles of Kmal in several bacterial species, such as Escherichia coli (Qian et al., 2016), Bacillus amyloliquefaciens (Fan et al., 2017), Mycobacterium tuberculosis (Bi et al., 2022), and Staphylococcus aureus (Shi et al., 2021), which demonstrates that Kmal exists in diverse prokaryotic organisms and participates in the regulation of various physiological processes. Even so, whether Kmal exists and affects protein functions in streptococci remains unknown. S. mutans is considered to be the most prevalent and cariogenic species in active carious lesions of humans, residing primarily in dental plaque, which is a biofilm that forms on the tooth surfaces. During the past decades, studies of S. mutans have focused on revealing the molecular mechanisms underlying the robust biofilm formation on tooth surfaces, the metabolism of a wide variety of carbohydrates obtained from the host diet, and the adaption of numerous environmental challenges (Lemos et al., 2019). Several studies have been performed to reveal the roles of PTMs in biofilm and cariogenic virulence. Wang et al. found that the phosphorylation of VicR could inhibit the expression of the glucosyltransferases gtfBC, thereby reducing the synthesis of extracellular polysaccharides (EPS), the major component of cariogenic biofilm (Wang et al., 2021). Acetylome study on the S. mutans depicted that acetylated substrates were globally altered in the biofilm state compared to the planktonic state, and the acetylated GtfBC showed decreased activities (Lei et al., 2021; Ma et al., 2021). Our previous study revealed that the S-glutathionylation of a thioredoxin-like protein is important for interspecies competition and cariogenicity of S. mutans(Li et al., 2020). These results suggest that various PTM types exist in S. mutans and participate in diverse physiological processes. The genome of S. mutans UA159 codes an acetyl coenzyme A carboxylase (ACC), which could synthesize malonyl-CoA through the carboxylation of acetyl-CoA (Ajdić et al., 2002), implying the existence of malonylation in this bacterium. Therefore, this study aimed to confirm the existence of Kmal in S. mutans and identify the malonylated sites globally. The present findings provide a systematic view of the functional roles of Kmal in various metabolic pathways of S. mutans.

Project description:In recent decades, the food system has been faced with the significant problem of increasing food waste. Indeed, as reported by the Food and Agriculture Organisation of the United Nations (FAO), approximately 1.3 billion tonnes of food are lost or wasted globally each year (FAO, 2011). For this reason, the European Union has implemented multiple strategies to ensure the sustainability of the food/feed sector. Among these, the Agenda 2030, later supported by the Green Deal, plays a major role, whose goal is to ensure a competitive, clean and circular economy (Fetting, 2020; Vastolo et al., 2022). For this reason, scientific research is investigating the use of non-edible biomass produced along the food chain as co-products (any product obtained from different agro-industrial processes) for livestock (Pinotti et al., 2020; Rakita et al., 2021). As shown by Govoni et al. (2023), the introduction of co-products (11-16%) to replace energy-rich food crops (such as cereals) would conserve 15.4-27.8 Mha of land, 3-19.6 km3 of blue water and 74.2-137.8 km3 of green water, representing an important strategy to ensure environmental sustainability. To date, although many co-products have already been tested (grape marcs, beet pulp, hempseed cake), several more are attracting the interest of the scientific community (Serena and Knudsen, 2007; Muhlack et al., 2018; Lanzoni et al., 2023a). Among these are camelina (Camelina Sativa L. Crantz) and cardoon (Cynara cardunculus), due to both the low environmental footprint and the high nutritional profile (Turco et al., 2019; Singh et al., 2023). More specifically, camelina and cardoon seeds are characterised by a good protein (25.9±2.07% and 16.7% on DM, respectively) and a high lipid (38.9±1.26% and 25-30% on DM, respectively) content (Genovese et al., 2015; Turco et al., 2019; Singh et al., 2023). As reported by Singh et al. (2023) and Petropoulos et al. (2018), the high fatty acid profile of camelina and cardoon seeds, rich in polyunsaturated fatty acids (55.6% and 65.43±0.08, respectively) and low in saturated fatty acids (9.04% and 13.23±0. 07%, respectively), prompted the food and feed industry to isolate the lipid fraction for nutritional and nutraceutical purposes, creating in parallel waste products. Among them, camelina cake (CAMC), cardoon cake (CC) and cardoon meal (CM) could be used in animal feed due to their high nutritional profile, as reported by Lolli et al. (2020), Nannucci et al. (2021) and Serrapica et al. (2019). However, the characterisation of the antioxidant profile and the study of bioactive peptides are still at an early stage. Therefore, in light of the above, the aim of this work was to investigate the modulation of total phenolic content (TPC) and antioxidant activity during the in vitro digestion process with 2′-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), ferric reducing antioxidant power (FRAP) and oxygen radical absorbance capacity (ORAC) assays of CAMC, CC, and CM. In parallel, peptidomics analyses of in vitro digested CAMC, CC, and CM have been carried out.

			Action	DRS
	MQtxt.rar	Other
	QEAGF160127_09.raw	Raw
	QEAGF160127_100.raw	Raw
	QEAGF160127_102.raw	Raw
	QEAGF160127_104.raw	Raw